Showing results (71-80 of 179) with videos related to
Sort By:
Pageof 18
European Journal of Immunology|October 1, 1991
In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivityA Meyerhans, G Dadaglio, J P Vartanian, et al.The Journal of Infectious Diseases|February 1, 1996
Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressorE Harrer, T Harrer, P Barbosa, et al.AIDS (London, England)|June 1, 1988
Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patientsB Autran, C M Mayaud, M Raphael, et al.Nature|July 23, 1987
AIDS virus-specific cytotoxic T lymphocytes in lung disordersF Plata, B Autran, L P Martins, et al.Clinical Immunology and Immunopathology|January 1, 1995
Cytotoxic CD8+ T lymphocytes reactive with human immunodeficiency virus-1 produce granulocyte/macrophage colony-stimulating factor and variable amounts of interleukins 2, 3, and 4 following stimulation with the cognate epitopeP Price, R P Johnson, D T Scadden, et al.The Journal of Experimental Medicine|October 1, 1994
Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1T J Tsomides, A Aldovini, R P Johnson, et al.Journal of Virology|May 1, 1993
Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigensC Jassoy, T Harrer, T Rosenthal, et al.The Journal of Infectious Diseases|October 7, 2000
Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in UgandaH Cao, I Mani, R Vincent, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2001
Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibodyR P Walensky, E S Rosenberg, M J Ferraro, et al.Journal of Immunological Methods|August 6, 1998
A mutant human beta2-microglobulin can be used to generate diverse multimeric class I peptide complexes as specific probes for T cell receptorsJ B Walter, D N Garboczi, Q R Fan, et al.Pageof 18